Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

Fig. 4

Correlation between Aβ40 and p-tau (181) in different clinical populations. To illustrate the correlation between Aβ40 and p-tau (181) (Table 2), the mean-centered concentrations of the two analytes in the total study population were plotted in NAD (a) and AD populations (b). Aβ40 and p-tau (181) concentrations were also plotted in a selection of multiple sclerosis (c) and FTD patients (d)

Back to article page